Are Your Patients Microdosing? People you wouldn’t normally associate with drug use are self-treating by microdosing with psychedelics. Doctors need to be kept in the loop. Medscape Medical News ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

Researchers from the Drug Safety Research Unit are calling for the robust monitoring of the safety of lecanemab, a promising new drug to treat Alzheimer’s Disease (AD). In a review article, published ...

Packaging error leads to recall of commonly-used drug - Certain packs of Boots paracetamol tablets have been recalled.

A new clinical trial reveals that the asthma drug omalizumab (Xolair) helps food-allergic children eat trigger foods safely.

In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR). This can occur in up to 49% of patients and usually presents as erythema, pruritus ...

Boots has urgently warned customers not to take one of its own-brand paracetamols and return any packets to stores ...

Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...

According to the agency, the 15-year-old company only presented efficacy claims for its branded medication and did not include any warnings or precautions for the tablets at a tradeshow.